Applications of Gold Nanoparticles in Brain Diseases across the Blood-Brain Barrier

被引:3
|
作者
Zhang, Jun [1 ]
Yang, Ting [1 ]
Huang, Wan [1 ]
Yu, Yao [1 ]
Sun, Taolei [1 ]
机构
[1] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Peoples R China
基金
中国国家自然科学基金;
关键词
Blood-brain barrier; gold nanoparticles; brain diseases; drug delivery; Alzheimer's disease; brain tumors; BETA-AMYLOID PEPTIDES; DRUG-DELIVERY; TRANSFERRIN RECEPTOR; TARGETED NANOPARTICLES; FOCUSED ULTRASOUND; PARTICLE-SIZE; CNS DELIVERY; BIODISTRIBUTION; DOXORUBICIN; CROSS;
D O I
10.2174/0929867329666220527121943
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Brain diseases, including Alzheimer's disease (AD), brain tumors and Parkinson's disease (PD), pose heavy pressure on the public healthcare system. The main obstacle to vanquish brain diseases is the blood-brain barrier (BBB), which is a selective barrier mainly formed by brain endothelial cells. BBB prevents almost all drugs from reaching the brain, thereby hindering drug delivery. Over the past few decades, considerable signs of progress have been made in crossing the BBB and treating brain diseases. Gold nanoparticles (AuNPs) demonstrate the characteristics of adjustable size, unique optical properties, flexible surface modification, and good biocompatibility, which all contribute AuNPs as a promising candidate in biomedical fields. This article reviews the structure and properties of BBB, and discusses main transport routes through the BBB. Besides, nanoparticles, specially AuNPs applied in brain diseases as main drug delivery platforms, are systematically summarized, emphasizing several methods to modify AuNPs, including tuning particle size and surface modification, which are aimed at promoting BBB penetration or prolonging circulation time of AuNPs. In addition, AuNPs utilized in brain diseases are introduced in detail from the aspects of brain imaging, AD, brain tumors, and PD. Prospects and challenges that need to be considered in further investigations and clinical transformation of AuNPs used in brain diseases are also included, hoping to bring new insights into the applications of AuNPs in brain diseases.
引用
收藏
页码:6063 / 6083
页数:21
相关论文
共 50 条
  • [21] Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier
    Tosi, Giovanni
    Duskey, J. T.
    Kreuter, Joerg
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (01) : 23 - 32
  • [22] Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier
    Wohlfart, Stefanie
    Khalansky, Alexander S.
    Gelperina, Svetlana
    Begley, David
    Kreuter, Joerg
    JOURNAL OF CONTROLLED RELEASE, 2011, 154 (01) : 103 - 107
  • [23] Nanoparticles and Blood-Brain Barrier: The Key to Central Nervous System Diseases
    Dominguez, Alazne
    Suarez-Merino, Blanca
    Goni-de-Cerio, Felipe
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (01) : 766 - 779
  • [24] Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model
    Sokolova, Viktoriya
    Mekky, Gehad
    van der Meer, Selina Beatrice
    Seeds, Michael C.
    Atala, Anthony J.
    Epple, Matthias
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [25] Crossing blood-brain barrier: Engineer gold nanoparticles for drug delivery in brain tumor treatment
    Mi, Jiaqi
    Song, Jie
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [26] Blood-brain barrier dysfunction in brain diseases: Clinical experience
    Schoknecht, Karl
    Shalev, Hadar
    EPILEPSIA, 2012, 53 : 7 - 13
  • [27] The impact of microglial activation on blood-brain barrier in brain diseases
    Carvalho da Fonseca, Anna Carolina
    Matias, Diana
    Garcia, Celina
    Amaral, Rackele
    Geraldo, Luiz Henrique
    Freitas, Catarina
    Souza Lima, Flavia Regina
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8 : 1 - 13
  • [28] Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases
    Gabathuler, Reinhard
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (03) : 195 - 204
  • [29] Drug Delivery across the Blood-Brain Barrier
    Khawli, Leslie A.
    Prabhu, Saileta
    MOLECULAR PHARMACEUTICS, 2013, 10 (05) : 1471 - 1472
  • [30] Blood-brain barrier in stress:: A gateway to various brain diseases
    Sharma, HS
    Westman, J
    Cervós-Navarro, J
    Dey, PK
    Nyberg, F
    NEW FRONTIERS IN STRESS RESEARCH: MODULATION OF BRAIN FUNCTION, 1998, : 259 - 276